| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |